Suma Krishnan

Suma Krishnan

Company: Krystal Biotech

Job title: Chief Executive Officer


Targeting Serious Rare Disease with Gene Therapy 1:30 pm

Outlining the rationale for targeting Netherton Syndrome and MOA of serine peptidase inhibitor kazal type 5 Discussing concurrent challenges in the rare disease clinical trial space across dystrophic epidermolysis bullosa, ARC1, and Netherton Syndrome Highlighting upcoming late-stage milestonesRead more

day: Day 2 PM - Track B

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.